Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
---|
06/21/2007 | US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
06/21/2007 | US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases |
06/21/2007 | US20070142409 3-Substituted-4-pyrimidone derivatives |
06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
06/21/2007 | US20070142391 Piperazine-2-carboxamide derivatives |
06/21/2007 | US20070142380 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
06/21/2007 | US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives |
06/21/2007 | US20070142375 Pyrrolidine derivatives as factor xa inhibitors |
06/21/2007 | US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
06/21/2007 | US20070142373 Quinoline derivatives as phosphodiesterase inhibitors |
06/21/2007 | US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands |
06/21/2007 | US20070142333 Cycloalkyl inhibitors of potassium channel function |
06/21/2007 | US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide |
06/21/2007 | US20070140960 Methods for imaging soluble a-beta |
06/21/2007 | DE60125036T2 Hydroxyformamidin-derivate und diese enthaltende medikamente Hydroxyformamidin derivatives and containing the same drug |
06/21/2007 | DE102005060468A1 Thienylpyridylcarboxamide Thienylpyridylcarboxamide |
06/21/2007 | CA2637740A1 Fused pyrrole derivatives |
06/21/2007 | CA2634168A1 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
06/21/2007 | CA2633541A1 N-(6-membered aromatic ring)-amido anti-viral compounds |
06/21/2007 | CA2633252A1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
06/21/2007 | CA2633023A1 Polycyclic indazole derivatives that are erk inhibitors |
06/21/2007 | CA2632030A1 Compounds which modulate the cb2 receptor |
06/21/2007 | CA2628952A1 Aspartic protease inhibitors |
06/20/2007 | EP1798230A1 Substituted alkylamine derivatives and methods of use |
06/20/2007 | EP1798229A1 Substituted biphenyl derivative |
06/20/2007 | EP1797100A1 Nitrate esters and their use for mitigating cellular damage |
06/20/2007 | EP1797080A1 Novel substituted thiophencarboxylic acid amides, production thereof and use thereof as medicaments |
06/20/2007 | EP1797069A2 Hiv inhibiting 5-heterocyclyl pyrimidines |
06/20/2007 | EP1797048A2 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
06/20/2007 | EP1797040A1 Muscarinic receptor antagonists |
06/20/2007 | EP1487824B1 Diamino-pyrimidines and their use as angiogenesis inhibitors |
06/20/2007 | EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
06/20/2007 | EP1366043B1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides |
06/20/2007 | CN1984922A Substituted prolines as inhibitors of hepatitis c virus NS3 serine protease |
06/20/2007 | CN1984910A Dimeric compounds of piperidine, piperazine or morpholine or their 7-membered analogs suitabale for the treatment of neurodegenerative disorders |
06/20/2007 | CN1984901A Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors. |
06/20/2007 | CN1984899A CXCR1 and CXCR2 chemokine antagonists |
06/20/2007 | CN1984897A Light-emitting device material and light-emitting device |
06/20/2007 | CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
06/20/2007 | CN1984888A Substituted azetidine compounds, their preparation and use as medicaments |
06/20/2007 | CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
06/20/2007 | CN1984564A Aminocarbonyl-substituted thiensulphonylamino (thio) carbonyltriazolin (thi) ones, methods for production and use thereof |
06/20/2007 | CN1982316A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
06/20/2007 | CN1321996C Process for preparing 2-iminopyrrolidine derivatives |
06/19/2007 | US7232909 Pyridine derivatives |
06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
06/19/2007 | US7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists |
06/19/2007 | US7232834 Quinolylpropylpiperidine derivatives, intermediates and compositions containing them, and preparation therefor |
06/19/2007 | US7232833 For therapy and prophylaxis of bacterial infections |
06/19/2007 | US7232819 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase |
06/14/2007 | WO2007066678A1 Therapeutic agent for corneal/conjuctival disease |
06/14/2007 | WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof |
06/14/2007 | WO2007065948A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
06/14/2007 | WO2007065669A1 Biaryl compounds useful as agonists of the gpr38 receptor |
06/14/2007 | WO2007065518A1 Pyridiazinone derivatives for tumour treatment |
06/14/2007 | WO2007065261A1 Plasminogen activator inhibitor-1 inhibitors |
06/14/2007 | WO2007050721A3 Heterocyclic aspartyl protease inhibitors |
06/14/2007 | WO2006099379A3 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
06/14/2007 | WO2006051397A8 Oligonucleotide probes |
06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
06/14/2007 | US20070135654 OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT HAVING AXIAL ASYMMETRY AND PROCESS FOR PRODUCING alpha-AMINO ACID AND DERIVATIVE THEREOF WITH THE SAME |
06/14/2007 | US20070135642 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast |
06/14/2007 | US20070135494 Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides |
06/14/2007 | US20070135492 Cannabinoid receptor 1 antagonists (CB1); use of 1,2,4-tri-substituted imidazoline derivatives in the treatment of obesity; use in combination with lipase inhibitor orlistat or lipstatin |
06/14/2007 | US20070135477 Benzimidazole derivatives and their use as protein kinases inhibitors |
06/14/2007 | US20070135468 Pyridyloxyalkanoic acid amide derivatives useful as fungicides |
06/14/2007 | US20070135428 Lactam containing cyclic diamines and derivatives as factor xa inhibitors |
06/14/2007 | US20070135426 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; thromboembolic disorder like deep vein thrombosis or pulmonary embolism; pyrazolo[3,4-c]pyridine derivatives; blood coagulation factor (trypsin-like serine protease enzymes) inhibitors |
06/14/2007 | US20070135402 Azetidine ring compounds and drugs comprising the same |
06/14/2007 | US20070135357 Anti-hypercholesterolemic compounds |
06/14/2007 | US20070134161 Methods of determining beta-iii tubulin expression |
06/14/2007 | CA2632719A1 Novel n-sulfamoyl-piperidineamides for the prophylaxis or treatment of obesity and related conditions |
06/14/2007 | CA2632217A1 Pyridiazinone derivatives for the treatment of tumours |
06/14/2007 | CA2632212A1 Plasminogen activator inhibitor-1 inhibitors |
06/14/2007 | CA2631231A1 Therapeutic agent for corneal/conjuctival disease |
06/13/2007 | EP1795526A1 N-substituted n-(4-piperidinyl)amide derivative |
06/13/2007 | EP1794152A1 Method for manufacturing enantiomeric imidazole compounds |
06/13/2007 | EP1794151A1 Dna-pk inhibitors |
06/13/2007 | EP1794135A1 Substituted heterocyclic compounds and methods of use |
06/13/2007 | EP1794130A1 Pyrazole compounds useful in the treatment of inflammation |
06/13/2007 | EP1794122A1 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase i |
06/13/2007 | EP1794117A2 Mercaptoamides as histone deacetylase inhibitors |
06/13/2007 | EP1793826A2 Chemical compounds |
06/13/2007 | EP1636213B1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity |
06/13/2007 | EP1611122B1 Substituted pyrazole compounds |
06/13/2007 | EP1437353B1 Alkyl ether derivatives or salts thereof |
06/13/2007 | EP1000040B1 Il-5 inhibiting 6-azauracil derivatives |
06/13/2007 | CN1980934A Novel indole derivatives as selective androgen receptor modulators (sarms) |
06/13/2007 | CN1980923A Polycyclic pyridines as potassium ion channel modulators |
06/13/2007 | CN1980920A Thiophene derivatives, their manufacture and use as pharmaceutical agents |
06/13/2007 | CN1980918A Substituted indazoles, compositions containing the same, and the preparation and use thereof |
06/13/2007 | CN1980917A Novel indole derivatives as selective androgen receptor modulators (SARMS) |
06/13/2007 | CN1980916A Chemokine receptor binding heterocyclic compounds |
06/13/2007 | CN1978444A Photochromic thiophene pyrrole mixed linkage type dithienylethene compounds, and their synthesizing and use |
06/13/2007 | CN1978443A Photochromic thiophene pyrazole heterocyclic mixed linkage type asymmetrical dithienylethene compounds, and their preparing method and use |
06/13/2007 | CN1321101C New retinoids for the treatment of emphysema |
06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
06/12/2007 | US7230104 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
06/12/2007 | US7230100 Having a predominantly cis configuration by coupling an S-oxide of a 2-oxymethyl- thiolane, dithiolane or oxathiolane with a nucleoside base in the presence of a tertiary amine, a Lewis acid of a Group 1B or 2B metal catalyst and deprotecting the intermediate formed |
06/12/2007 | US7230098 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |